JA Raaijmakers

957 total citations
12 papers, 795 citations indexed

About

JA Raaijmakers is a scholar working on Physiology, Immunology and Allergy and Immunology. According to data from OpenAlex, JA Raaijmakers has authored 12 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 5 papers in Immunology and Allergy and 3 papers in Immunology. Recurrent topics in JA Raaijmakers's work include Asthma and respiratory diseases (9 papers), Food Allergy and Anaphylaxis Research (2 papers) and Inhalation and Respiratory Drug Delivery (2 papers). JA Raaijmakers is often cited by papers focused on Asthma and respiratory diseases (9 papers), Food Allergy and Anaphylaxis Research (2 papers) and Inhalation and Respiratory Drug Delivery (2 papers). JA Raaijmakers collaborates with scholars based in Netherlands and United States. JA Raaijmakers's co-authors include Leo Koenderman, F. P. V. Maesen, JW Lammers, Eric Caldenhoven, Pieter Zanen, Maureen Rutten‐van Mölken, PL Bruijnzeel, Frank L. Custers, Eddy van Doorslaer and P. H. M. Kuijper and has published in prestigious journals such as Blood, European Respiratory Journal and Value in Health.

In The Last Decade

JA Raaijmakers

12 papers receiving 741 citations

Peers

JA Raaijmakers

PHYSI

PRM

IMMUN

IA

RHEUM

A. Prudhomme France

P Zanon Italy

Mariana Fernandes United Kingdom

Eugene J. Sullivan United States

Matthew Parsons United States

Ian Landells Canada

Claire Bethune United Kingdom

Daniel C. Moreira United States

M. Fazio Italy

Taro Okayama Japan

A. Prudhomme France

JA Raaijmakers

318 ×0.6

PHYSI

336 ×1.2

PRM

79 ×0.3

IMMUN

119 ×0.7

IA

60 ×0.6

RHEUM

Citations per year, relative to JA Raaijmakers JA Raaijmakers (= 1×) peers A. Prudhomme

Countries citing papers authored by JA Raaijmakers

Since Specialization

Citations

This map shows the geographic impact of JA Raaijmakers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Raaijmakers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Raaijmakers more than expected).

Fields of papers citing papers by JA Raaijmakers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JA Raaijmakers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Raaijmakers. The network helps show where JA Raaijmakers may publish in the future.

Co-authorship network of co-authors of JA Raaijmakers

This figure shows the co-authorship network connecting the top 25 collaborators of JA Raaijmakers. A scholar is included among the top collaborators of JA Raaijmakers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JA Raaijmakers. JA Raaijmakers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Raaijmakers, JA, et al.. (2015). Reimbursement of Orphan and Expensive Drugs In The Netherlands: Exploration of Essential Criteria In The Decision Making Process. Value in Health. 18(7). A546–A546. 1 indexed citations

2.

Dijk, Thamar B. van, et al.. (1999). A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene.. PubMed. 163(5). 2674–80. 24 indexed citations

3.

Raaijmakers, JA, et al.. (1997). Bronchial and skin reactivity in asthmatic patients with and without atopic dermatitis. European Respiratory Journal. 10(5). 1033–1040. 19 indexed citations

4.

Raaijmakers, JA, et al.. (1996). Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. European Respiratory Journal. 9(8). 1684–1688. 171 indexed citations

5.

Bracke, Madelon, et al.. (1996). Cloning and characterization of Fc alpha Rb, a novel Fc alpha receptor (CD89) isoform expressed in eosinophils and neutrophils. Blood. 88(11). 4229–4238. 23 indexed citations

6.

Bracke, Madelon, et al.. (1996). Cloning and characterization of Fc alpha Rb, a novel Fc alpha receptor (CD89) isoform expressed in eosinophils and neutrophils. Blood. 88(11). 4229–4238. 31 indexed citations

7.

Mölken, Maureen Rutten‐van, et al.. (1995). Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. European Respiratory Journal. 8(6). 888–898. 167 indexed citations

8.

Bruggen, Tjomme van der, Eric Caldenhoven, Deon Kanters, et al.. (1995). Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. Blood. 85(6). 1442–1448. 102 indexed citations

9.

Raaijmakers, JA, et al.. (1994). RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood. 83(12). 3697–3704. 19 indexed citations

10.

Raaijmakers, JA, et al.. (1994). RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood. 83(12). 3697–3704. 124 indexed citations

11.

Kuijper, P. H. M., et al.. (1992). In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood. 79(7). 1836–1841. 13 indexed citations

12.

Kuijper, P. H. M., et al.. (1992). In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood. 79(7). 1836–1841. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact